Preventive Effect of Eucalyptol on the Formation of Aorta Lesions in the Diabetic‑Atherosclerotic Rat
Abstract
Background: Glycation, inflammation, and oxidative stress are the cardinal motivators of diabetes vascular complications. Here, we studied the effect of eucalyptol(EUC) on the formation of atheromatous lesions, glycation, oxidative stress, and inflammatory markers as well as insulin resistance, lipid profile, and activity of glyoxalase‑1(GLO‑I) in the atherosclerotic rat model.
Methods: Diabetic‑atherosclerosis induced in rats with a combination of streptozotocin and atherogenic diet. Two groups of rats, normal and diabetic‑atherosclerotic, were treated intragastrically with EUC(200 mg/kg) once daily for 3 months. Fasting blood sugar(FBS), insulin, insulin resistance index, lipid profile, the activity of GLO‑I, low‑density lipoprotein(LDL) glycation and oxidation markers, inflammatory markers, creatinine in the serum, and proteinuria in the urine of all rats were
determined.
Results: EUC inhibited the formation of any atheromatous lesions in atherosclerotic rats. Further, EUC displayed the lowering effect on glycemia, insulin resistance, LDL glycation, and oxidation products, and tumor necrosis factor(TNF)‑α as well as it exhibited the improving
effect on lipid profile, the activity of GLO‑I, and renal function in the diabetic rat(P<0.001).
Conclusions: EUC prevented the formation of the atheromatous lesions and improved renal function in the atherosclerotic rat model due to a reduction of glycation, oxidative stress, and inflammatory
mediators.
Keywords
Full Text:
PDFReferences
Forbes JM CM. Mechanisms of diabetic complications. Physiol Rev 2013;93:137‑88.2. Mahdavifard S, Nakhjavani M. Effect of glutamine on oxidative stress, inflammatory, and glycation markers, and the activity
of glyoxalase system in diabetic rats with atherosclerosis.
J Mazandaran Univ Med Sci 2019;28:33‑42.3. Mahdavifard S, Nakhjavani M. Effect of cysteine on transforming
growth factor β1 as the main cause of renal disorder in a rat
model of diabetic nephropathy. J Mazandaran Univ Med Sci 2019;29:95‑101.4. Raghav A, Ahmad J, Noor S, Alam K, Mishra BK. Glycated albumin and the risk of chronic kidney disease in subjects with type 2 diabetes: A study in North Indian population. Diabetes Metab Syndr 2018;12:381‑5.5. Song F, Schmidt AM. Glycation and insulin resistance novel mechanisms and unique targets? Arterioscler Thromb Vasc Biol 2012;32:1760‑5.6. Shayesteh R, Kamalinejad M, Adiban H, Kardan A, Keyhanfar F, Eskandari MR. Cytoprotective effects of pumpkin
(Cucurbita Moschata) fruit extract against oxidative stress and
carbonyl stress. Drug Res (Stuttg) 2017;67:576‑82.7. Maessen DE, Stehouwer CD, Schalkwijk CG. The role of
methylglyoxal and the glyoxalase system in diabetes and other
age‑related diseases. Clin Sci (Lond) 2015;128:839‑61.8. Nichols TC, Merricks EP, Bellinger DA, Raymer RA, Yu J, Lam D3, et al. Oxidized LDL and fructosamine associated
with severity of coronary artery atherosclerosis in insulin
resistant pigs fed a high fat/high NaCl Diet. PLoS One 2015;10:e0132302.9. Linghu KG, Wu GP, Fu LY, Yang H, Li HZ, Chen Y, et al.
,8‑cineole ameliorates lps‑induced vascular endothelium dysfunction in mice via PPAR‑gamma dependent regulation of NF‑kappaB. Front Pharmacol 2019;10:178.10. Lima PR de Melo MT, Carvalho KM, de Oliveira ÍB, Arruda BR, de Castro Brito GA, et al. 1,8‑cineole (eucalyptol) ameliorates cerulein‑induced acute pancreatitis via modulation of cytokines, oxidative stress and NF‑κB activity in mice. Life Sci 2013;10:24‑6.11. Matthews DR HJ, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance
and beta cell function from fasting plasma glucose and insulin
concentrations in man. Diabetologi 1985;28:412‑9.12. Mahdavifard S, Bathaie SZ, Nakhjavani M, Taghikhani M. The synergistic effect of antiglycating agents (MB‑92) on inhibition
of protein glycation, misfolding and diabetic complications in
diabetic‑atherosclerotic rat. Eur J Med Chem 2016;121:892‑902.13. Schaefer EJ, Otokozawa S, Ai M. Limitations of direct methods and the reference method for measuring HDL and LDL cholesterol. Clin Chem 2011;57:1081‑3. author reply 3.14. Younis N, Charlton‑Menys V, Sharma R, Soran H, Durrington PN. Glycation of LDL in non‑diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro.
Atherosclerosis 2009;202:162‑8.15. Ahotupa M, Vasankari TJ. Baseline diene conjugation in LDL lipids: An indicator of circulating oxidized LDL. Free Radic Biol Med 1999;27:1141‑50.16. Mahdavifard S, Bathaie S, Nakhjavani M, Heidarzadeh H. L‑cysteine is a potent inhibitor of protein glycation on both albumin and LDL, and prevents the diabetic complications in diabetic–atherosclerotic rat. Food Res Int 2014;62:909‑16.17. Witko‑Sarsat V, Nguyen‑Khoa T, Jungers P, Drüeke T, Descamps‑Latscha B. Advanced oxidation protein products as
a novel molecular basis of oxidative stress in uraemia. Nephrol
Dial Transplant 1999;14(Suppl 1):76‑8.18. Huang D, Refaat M, Mohammedi K, Jayyousi A, Al Suwaidi J, Abi Khalil C. Macrovascular complications in patients with diabetes and prediabetes. BioMed Res Int 2017;2017:7839101.19. Cho KH. 1,8‑cineole protected human lipoproteins from modification by oxidation and glycation and exhibited serum lipid‑lowering and anti‑inflammatory activity in zebrafish. BMB Rep 2012;45:565‑70.20. Tezuka Y, Nakaya I, Nakayama K, Nakayama M, Yahata M, Soma J. Methylglyoxal as a prognostic factor in patients with chronic kidney disease. Nephrology (Carlton) 2019;24:943‑50.21. Al‑Trad B, Alkhateeb H, Alsmadi W, Al‑Zoubi M. Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat‑diet/streptozotocin‑induced diabetic rat. Life Sci 2019;216:183‑8.22. Lima PR, de Melo TS, Carvalho KM, de Oliveira IB, Arruda BR, de Castro Brito GA, et al. 1,8‑cineole (eucalyptol) ameliorates cerulein‑induced acute pancreatitis via modulation of cytokines, oxidative stress and NF‑kappaB activity in mice. Life Sci 2013;92:1195‑201.23. Menezes RR Godin A, Rodrigues FF, Coura GME, Melo ISF, Brito AMS, et al. Thiamine and riboflavin inhibit production of cytokines and increase the anti‑inflammatory activity of a corticosteroid in a chronic model of inflammation induced by complete Freund’s adjuvant. Pharmacol Rep 2017;69:1036‑43.24. Steinberg D, Witztum JL. Oxidized low‑density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol 2010;30:2311‑6.25. Cai R, Chen S, Jiang S. [Chlorogenic acid inhibits non‑enzymatic
glycation and oxidation of low density lipoprotein]. Zhejiang Da
Xue Xue Bao Yi Xue Ban 2018;47:27‑34.26. Kawanami D, Matoba K, Utsunomiya K. Dyslipidemia in diabetic nephropathy. Replace Ther 2016;2:16.27. Gnudi L, Thomas SM, Viberti G. Mechanical forces in diabetic kidney disease: A trigger for impaired glucose metabolism. J Am Soc Nephrol 2007;18:2226‑32.28. Nozako M, Koyama T, Nagano C, Sato M, Matsumoto S, Mitani K, et al. An atherogenic paigen‑diet aggravates nephropathy in type 2 diabetic OLETF rats. PLoS One 2015;10:e0143979.29. Ahmadvand H, Mahdavifard S. Protective effect of thioctic acid on renal ischemia‑reperfusion injury in rat. Int J Prev Med 2019;10:176.